28 related articles for article (PubMed ID: 8496818)
1. New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models.
Sharma AK; Singh S; Bhat M; Gill K; Zaid M; Kumar S; Shakya A; Tantray J; Jose D; Gupta R; Yangzom T; Sharma RK; Sahu SK; Rathore G; Chandolia P; Singh M; Mishra A; Raj S; Gupta A; Agarwal M; Kifayat S; Gupta A; Gupta P; Vashist A; Vaibhav P; Kathuria N; Yadav V; Singh RP; Garg A
Sci Rep; 2023 Sep; 13(1):16420. PubMed ID: 37775650
[TBL] [Abstract][Full Text] [Related]
2. Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation.
Diller DJ; Hobbs DW
J Comput Aided Mol Des; 2007 Jul; 21(7):379-93. PubMed ID: 17549583
[TBL] [Abstract][Full Text] [Related]
3. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB
J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
[TBL] [Abstract][Full Text] [Related]
4. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.
Lynch JJ; Wallace AA; Stump GL; Stupienski RF; Kothstein T; Gehret JR
J Pharmacol Exp Ther; 1996 May; 277(2):671-8. PubMed ID: 8627544
[TBL] [Abstract][Full Text] [Related]
5. Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.
Wallace AA; Stupienski RF; Baskin EP; Appleby SD; Kothstein T; Gehret JR; King SW; Remy DC; Lynch JJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):168-75. PubMed ID: 7714763
[TBL] [Abstract][Full Text] [Related]
6. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
[TBL] [Abstract][Full Text] [Related]
8. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
[TBL] [Abstract][Full Text] [Related]
9. RP 58866 and its active enantiomer RP 62719 (terikalant): blockers of the inward rectifier K+ current acting as pure class III antiarrhythmic agents.
Escande D; Mestre M; Cavero I; Brugada J; Kirchhof C
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S106-13. PubMed ID: 1279302
[TBL] [Abstract][Full Text] [Related]
10. Ionic mechanisms of ischemia-related ventricular arrhythmias.
Ducceschi V; Di Micco G; Sarubbi B; Russo B; Santangelo L; Iacono A
Clin Cardiol; 1996 Apr; 19(4):325-31. PubMed ID: 8706374
[TBL] [Abstract][Full Text] [Related]
11. Development of class III antiarrhythmic agents.
Hondeghem LM
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S17-22. PubMed ID: 1279304
[TBL] [Abstract][Full Text] [Related]
12. Restacorin, a new antiarrhythmic drug: a review of its electrophysiologic and hemodynamic properties.
Tuininga YS; Crinjns HJ; Kozma C; Rabloczky G; Jonkman JH; Lie KI
Int J Clin Pharmacol Ther; 1994 Jun; 32(6):278-81. PubMed ID: 7921525
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
